Theralase Technologies Inc (TLTFF)

[HiddenGem69]

Key Investment Highlights:

Working on breakthrough bladder cancer destruction technology and has achieved tremendous success in pre-clinical trials
Proven clinical technology (TLC-1000) and commercial therapeutic laser business and brand developed over last 17 years, currently generating ~2M of revenue annually
Rollout of new TLC-2000 technology in 2014, along with a new recurring revenue business model
Strategic agreements in place with world renowned institutions to help advance research and mitigate expenses
Competitive technical advantages (Cellular pathways: iNOS, ATP, Na+ / K+)
Future technology (patented biofeedback technology and patented PDC cancer destruction)
IP protection (multiple issued patents)
Large addressable US markets ($ billions)
No debt
Positive cash flow / double digit growth
Lots of opportunity for short-term and long-term growth (revenue & profit)
Experienced management team (20+ years)
Clear vision and execution strategy